HOME >> MEDICINE >> NEWS
New therapeutic targets for neurodegenerative diseases

nder certain conditions, i.e. sensory symptoms, motor symptoms, etc. and that can be induced in these animals. And they are examining if these substances that have proved to be interesting with the in vitro cells are also efficacious in these experimental models of the diseases.

Moreover, over the past few years they have had the opportunity to study samples of brains of patients who have died of some neurodegenerative illness, such as, for example, multiple sclerosis. The illnesses leaves a mark in these samples and, although the brain has been at a terminal stage of the illness, they can investigate to see if there are signs of alterations to the molecules similar to those observed in the experiments, both with cells and with the animals. In this way it can be determined if the molecular targets discovered experimentally are relevant or not to the neurodegenerative processes and, if they are, develop pharmaceutical medicines that can neutralise these processes or the elements that enable them to progress, the goal being to halt the process of death.

In collaboration with neurologists they have also been able to access biological samples of patients who have given their consent and donated them to research. Biological samples such as, fundamentally, blood, given that changes in blood plasma that may indicate alterations at the brain level can be identified.

In search of biological samples

All this is a dynamic process that enables clues to be found and which are, in some cases, relevant for developing pharmaceutical drugs that can halt, or at least slow down, the course of a neurodegenerative illness. Apart from finding these molecules or targets that interact with pharmaceutical medicines, in order to stop the process of progressive deterioration, substances that favour the survival of the neurones and oligodendrocytes are also sought; substances such as, for example, antioxidants, given that, in many of
'"/>

Contact: Irati Kortabitarte
iratik@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
10-May-2007


Page: 1 2 3

Related medicine news :

1. Shark cartilage shows no benefit as a therapeutic agent for lung cancer
2. OCT1 required for therapeutic effects of diabetes drug Metformin
3. NeuroRx changes name to Neurotherapeutics
4. Olive Leaf report documents promising therapeutic interventions for 9-11 workers
5. T cells activated to fight HIV basis for dendritic cell therapeutic vaccine
6. Cerebrospinal fluid used to deliver therapeutics for Lou Gehrigs disease to brain
7. University to develop new therapeutics for cancer
8. Exubera: So far no evidence available of an additional therapeutic benefit
9. Nano-particles effective in killing cancer with one-two punch of chemotherapeutics
10. Researchers identify target for therapeutic drugs to fight most common adult brain cancer
11. Cedars-Sinai researchers demonstrate a new way to switch therapeutic genes on and off

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New therapeutic targets for neurodegenerative diseases

(Date:8/28/2014)... The need for larger space has become more pressing ... new location - 4700 Bryant Irvin Court, Fort Worth, TX ... than TLC had in the past, as well as new ... new location because it represents a good fit for our ... size compared to the current one, the building itself is ...
(Date:8/28/2014)... The next episode of “Extreme Weight Loss” ... He’s a drama coach who longs to audition for ... achieving that dream impossible. , Featuring a unique, non-competitive ... Tuesday, September 2 (9:00-11:00 p.m., ET/PT) on the ABC ... smile on the outside to hide the self-doubt and ...
(Date:8/27/2014)... (PRWEB) August 28, 2014 A St. ... Danis & Lowe reports that the C.R. Bard ... thousands of consolidated transvaginal mesh lawsuits, recently filed a ... #136 pertains to the pretrial discovery process, and more ... sensitive evidence. , Carey Danis & Lowe is a ...
(Date:8/27/2014)... Texas (PRWEB) August 28, 2014 Spine ... prominent online source of information on spinal health. Now, ... back pain, or people suffering from back pain symptoms. ... sciatica surgery, cervical/neck surgery, and lumbar spine surgery. , ... muscle ache, shooting or stabbing pain, pain radiating down ...
(Date:8/27/2014)... DiaSorin has announced that their new ... will feature guest speaker Dr. Gregory A. Plotnikoff, a ... and Healing Integrative Medicine. Dr. Plotnikoff serves as an ... Health and Healing and as Senior Consultant, Center for ... also serves as a co-editor of the new journal ...
Breaking Medicine News(10 mins):Health News:“Extreme Weight Loss”: Rod’s Journey Begins at the University of Colorado Anschutz Health and Wellness Center 2Health News:Carey Danis & Lowe Reports On New Court Order in C.R. Bard Transvaginal Mesh MDL 2Health News:Spine Guide Offering New Overview of Surgical Options For Back Pain 2Health News:DiaSorin Announces New Webinar in Their Annual Vitamin D Series 2Health News:DiaSorin Announces New Webinar in Their Annual Vitamin D Series 3
(Date:8/27/2014)... North American lighting leader OSRAM SYLVANIA has been ... OSRAM ITOS ® PHASER ® 3000, the industry,s ... and surgical head lamps that delivers the same brightness as ... "We,re honored to be recognized by R&D ... of the past year," said Andreas Osten , medical ...
(Date:8/27/2014)...  CVS Caremark (NYSE: CVS ) announced ... with MedStar Health, a leading health care system with ... the Washington, DC , region, which ... for patients. Through this clinical affiliation, MedStar Health patients ... counseling, chronic disease monitoring and wellness programs at CVS/pharmacy ...
(Date:8/27/2014)... LYNDHURST N.J. and NINGBO, China ... ("Amerigen") and the Ningbo Menovo Pharmaceutical Co., Ltd, ("Menovo") ... regarding the development of generic pharmaceuticals, primarily targeting ... terms of the agreement, Amerigen and Menovo will jointly ... the United States . Menovo will be responsible ...
Breaking Medicine Technology:OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3CVS Caremark Announces New Clinical Affiliation with MedStar Health 2CVS Caremark Announces New Clinical Affiliation with MedStar Health 3Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co., Ltd, today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market 2
Cached News: